"Partneringreview 2006 - Volume 2: Therapy Area" provides an in depth view into the deals and alliances by therapeutic area announced in 2005, in a clear and accessible format.
The report reviews over 2,600 deal announcements in therapeutic areas - oncology, infectious disease, cardiovascular, circulatory, central nervous system, autoimmune, inflammation, metabolism, respiratory, gastrointestinal, musculoskeletal, sensory organ, oral health, genitourinary, gynecology, dermatology, blood system, lymphatic system, and accident/hospital/trauma.
Each sector is further divided to analyze deals by company, industry sector, and stage of development. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.
Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.
All the year's deals at a glance.
Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005's deals into focus in one place.
Partneringreview is a comprehensive summary of the year's deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition.
"Partneringreview 2006" is the full report of all the deals data collected in 2005, providing a broad perspective of deal announcements, and incorporates all six volumes.
|
INTRODUCTION
About Partneringreview
Full contents of Partneringreview 2006
Review of deal making in 2005
Deals announced by therapy area
VOLUME 2: THERAPY AREA
Introduction: Deals announced by therapy area
Chapter 1: Oncology
Deals in the oncology therapy area by company
Deals in the oncology therapy area by industry focus
Deals in the oncology therapy area by development stage
Chapter 2: Infectious disease
Deals in the infectious disease therapy area by company
Deals in the infectious disease therapy area by industry focus
Deals in the infectious disease therapy area by development stage
Chapter 3: Cardiovascular/Circulatory
Deals in the cardiovascular/circulatory therapy area by company
Deals in the cardiovascular/circulatory therapy area by industry focus
Deals in the cardiovascular/circulatory therapy area by development stage
Chapter 4: Central Nervous System
Deals in the central nervous system therapy area by company
Deals in the central nervous system therapy area by industry focus
Deals in the central nervous system therapy area by development stage
Chapter 5: Autoimmune/Inflammation
Deals in the autoimmune/inflammation therapy area by company
Deals in the autoimmune/inflammation therapy area by industry focus
Deals in the autoimmune/inflammation therapy area by development stage
Chapter 6: Metabolism
Deals in the metabolism therapy area by company
Deals in the metabolism therapy area by industry focus
Deals in the metabolism therapy area by development stage
Chapter 7: Respiratory
Deals in the respiratory therapy area by company
Deals in the respiratory therapy area by industry focus
Deals in the respiratory therapy area by development stage
Chapter 8: Gastrointestinal
Deals in the gastrointestinal therapy area by company
Deals in the gastrointestinal therapy area by industry focus
Deals in the gastrointestinal therapy area by development stage
Chapter 9: Musculoskeletal
Deals in the musculoskeletal therapy area by company
Deals in the musculoskeletal therapy area by industry focus
Deals in the musculoskeletal therapy area by development stage
Chapter 10: Sensory Organ/Oral Health
Deals in the sensory organ/oral health therapy area by company
Deals in the sensory organ/oral health therapy area by industry focus
Deals in the sensory organ/oral health therapy area by development stage
Chapter 11: Genitourinary/Gynecology
Deals in the genitourinary/gynecology therapy area by company
Deals in the genitourinary/gynecology therapy area by industry focus
Deals in the genitourinary/gynecology therapy area by development stage
Chapter 12: Dermatology
Deals in the dermatology therapy area by company
Deals in the dermatology therapy area by industry focus
Deals in the dermatology therapy area by development stage
Chapter 13: Blood/Lymphatic System
Deals in the blood/lymphatic system therapy area by company
Deals in the blood/lymphatic system therapy area by industry focus
Deals in the blood/lymphatic system therapy area by development stage
Chapter 14: Accident/Hospital/Trauma
Deals in the accident/hospital/trauma therapy area by company
Deals in the accident/hospital/trauma therapy area by industry focus
Deals in the accident/hospital/trauma therapy area by development stage
Chapter 15: List of deals
GLOSSARY
List of Tables
Table 1 Top oncology area dealmaking companies in 2005
Table 2 Top infectious disease area dealmaking companies in 2005
Table 3 Top cardiovascular/circulatory area dealmaking companies in 2005
Table 4 Top central nervous system area dealmaking companies in 2005
Table 5 Top autoimmune/inflammation area dealmaking companies in 2005
Table 6 Top metabolism area dealmaking companies in 2005
Table 7 Top respiratory area dealmaking companies in 2005
Table 8 Top gastrointestinal area dealmaking companies in 2005
Table 9 Top musculoskeletal area dealmaking companies in 2005
Table 10 Top sensory organ/oral health area dealmaking companies in 2005
Table 11 Top genitourinary/gynecology area dealmaking companies in 2005
Table 12 Top dermatology area dealmaking companies in 2005
Table 13 Top blood/lymphatic system area dealmaking companies in 2005
Table 14 Top accident/hospital/trauma area dealmaking companies in 2005
List of Figures
Fig. i.1 Deals announced by therapy focus
Fig. 1.1 Announcements in the oncology therapy area by company
Fig. 1.2 Announcements in the oncology therapy area by industry sector
Fig. 1.3 Announcements in the oncology therapy area by development stage
Fig. 2.1 Announcements in the infectious disease therapy area by company
Fig. 2.2 Announcements in the infectious disease therapy area by industry sector
Fig. 2.3 Announcements in the infectious disease therapy area by development stage
Fig. 3.1 Announcements in the cardiovascular/circulatory therapy area by company
Fig. 3.2 Announcements in the cardiovascular/circulatory therapy area by industry sector
Fig. 3.3 Announcements in the cardiovascular/circulatory therapy area by development
Fig. 4.1 Announcements in the central nervous system therapy area by company
Fig. 4.2 Announcements in the central nervous system therapy area by industry sector
Fig. 4.3 Announcements in the central nervous system therapy area by development stage
Fig. 5.1 Announcements in the autoimmune/inflammation therapy area by company
Fig. 5.2 Announcements in the autoimmune/inflammation therapy area by industry sector
Fig. 5.3 Announcements in the autoimmune/inflammation therapy area by development stage
Fig. 6.1 Announcements in the metabolism therapy area by company
Fig. 6.2 Announcements in the metabolism therapy area by industry sector
Fig. 6.3 Announcements in the metabolism therapy area by development stage
Fig. 7.1 Announcements in the respiratory therapy area by company
Fig. 7.2 Announcements in the respiratory therapy area by industry sector
Fig. 7.3 Announcements in the respiratory therapy area by development stage
Fig. 8.1 Announcements in the gastrointestinal therapy area by company
Fig. 8.2 Announcements in the gastrointestinal therapy area by industry sector
Fig. 8.3 Announcements in the gastrointestinal therapy area by development stage
Fig. 9.1 Announcements in the musculoskeletal therapy area by company
Fig. 9.2 Announcements in the musculoskeletal therapy area by industry sector
Fig. 9.3 Announcements in the musculoskeletal therapy area by development stage
Fig. 10.1 Announcements in the sensory organ/oral health therapy area by company
Fig. 10.2 Announcements in the sensory organ/oral health therapy area by industry sector
Fig. 10.3 Announcements in the sensory organ/oral health therapy area by development
Fig. 11.1 Announcements in the genitourinary/gynecology therapy area by company
Fig. 11.2 Announcements in the genitourinary/gynecology therapy area by industry sector
Fig. 11.3 Announcements in the genitourinary/gynecology therapy area by development
Fig. 12.1 Announcements in the dermatology therapy area by company
Fig. 12.2 Announcements in the dermatology therapy area by industry sector
Fig. 12.3 Announcements in the dermatology therapy area by development stage
Fig. 13.1 Announcements in the blood/lymphatic system therapy area by company
Fig. 13.2 Announcements in the blood/lymphatic system therapy area by industry sector
Fig. 13.3 Announcements in the blood/lymphatic system therapy area by development stage
Fig. 14.1 Announcements in the accident/hospital/trauma therapy area by company
Fig. 14.2 Announcements in the accident/hospital/trauma therapy area by industry sector
Fig. 14.3 Announcements in the accident/hospital/trauma therapy area by development
Share this report
Other tasks Related Markets Therapeutic Area Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
